22 July 2015

Swindon Team involved in internationally recognised dementia delay drug.

Dementia drug trialA team based at the Victoria Centre in Swindon has been involved in the new drug which could delay dementia.

The Kingshill Research Centre is Avon & Wiltshire Mental Health Partnership Trust's clinical trials centre. Kingshill has been involved in trialling the new drug, which may cut the rate of the dementia's progression in a third of people with early onset Alzheimer's disease.

Kingshill's participation with the study has spanned 5 years and it brings great satisfaction to the team to see the study results published today and the international media coverage that has resulted.

Emma Murray, Clinical Trial Administrator said "When the study started in 2010 we recruited ten patients who participated in a monthly infusion. We are now about to enter the next phase of the study and look forward to being able to give more service users the opportunity to be involved in dementia research studies."

The Kingshill Research Centre specialises in trialling dementia drugs. The team has been involved in most clinical trials for drugs routinely used by people with a dementia diagnosis. Clinical trials help us evaluate the safety and effectiveness of new drugs, as well as looking at combinations of new and existing drugs or how they work in other conditions.

 

Cookies on our website

Cookies are used to ensure you get the best browsing experience. No personally identifiable information is collected.
By using our site you agree to these cookies being used. For more information please see our Cookie Policy.